Avoid common mistakes on your manuscript.
Correction to: International Journal of Clinical Oncology (2022) 27:563–573 https://doi.org/10.1007/s10147-021-02091-8
In the original publication, in Table 6, the p-values of Number of metastases, mean ± SD under IMDC intermediate risk were published incorrectly. The corrected version of Table 6 is given in this correction.
The original publication has been updated.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Kato, R., Naito, S., Numakura, K. et al. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study. Int J Clin Oncol 28, 726–727 (2023). https://doi.org/10.1007/s10147-023-02331-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-023-02331-z